A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

Angiomotin (Amot) is one of several identified angiostatin receptors expressed by the endothelia of angiogenic tissues. We have shown that a DNA vaccine targeting Amot overcome immune tolerance and induce an antibody response that hampers the progression of incipient tumors. Following our observatio...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Arigoni, Maddalena, Barutello, Giuseppina, Lanzardo, Stefania, Longo, Dario, Aime, Silvio, Curcio, Claudia, Iezzi, Manuela, Zheng, Yujuan, Barkefors, Irmeli, Holmgren, Lars, Cavallo, Federica
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Netherlands 2012
Pynciau:
Original Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3338916/
https://ncbi.nlm.nih.gov/pubmed/22426512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-012-9263-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg